Key facts
- Nordiq’s last known valuation is $2.2M (Feb 2022).
- It has raised $500K; the latest was Later Stage VC in Apr 2025.
- Notable investors include Farvatn Venture, Aleap, Cartavio (Norway), Research Council of Norway.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Nordiq
- ·The full record, as it builds
Funding rounds
No funding rounds for Nordiq are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Nordiq
Manufacturer of monitoring devices designed to reduce stress levels and monitor oxygen and other parameters in critical situations. The company specializes in developing devices such as emergency medical devices, first aid equipment, sports wearables, and home monitoring for respiration, pulse, and blood oxygen levels, enabling hospitals to monitor the airway and breathing problems to prevent deaths.
- Sector
- Healthcare
- HQ
- Trondheim, Norway
- Founded
- 2017
- Employees
- 8
- Website
- nordiqproducts.com/
- Ownership
- Privately Held (backing)
Nordiq doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nordiq shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nordiq in its N-PORT filings yet. We sweep new filings monthly.